Who owns Insight Molecular Diagnostics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IMDX from SEC Form 13F filings across 40 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 40 institutions disclosed 18.5M shares of Insight Molecular Diagnostics Inc. worth $108.9M — about 50.2% of shares outstanding; the largest disclosed holder is BROADWOOD CAPITAL INC. Source: SEC Form 13F filings, parsed by EvidInvest.
40
13F holders
$108.9M
value, 2026 filers
50.2%
of shares outstanding (18.5M sh)
12
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of IMDX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BROADWOOD CAPITAL INC | 12.7M | $74.8M | 3.9% | 34.5% | +6.3% |
| 2 | AWM Investment Company, Inc. | 2.8M | $16.7M | 1.5% | 7.7% | +1.1% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 735,847 | $4.3M | 0.0% | 2% | +37.0% |
| 4 | PURA VIDA INVESTMENTS, LLC | 484,845 | $2.9M | 7.7% | 1.3% | -48.8% |
| 5 | Family Office Research LLC | 368,849 | $2.2M | 0.8% | 1% | +189.8% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 256,903 | $1.5M | 0.0% | 0.7% | -2.0% |
| 7 | FNY Investment Advisers, LLC | 182,561 | $1.1M | 0.4% | 0.5% | -26.2% |
| 8 | JANE STREET GROUP, LLCNEW | 157,682 | $930,324 | 0.0% | 0.4% | new |
| 9 | BlackRock, Inc. | 150,521 | $888,074 | 0.0% | 0.4% | +11.2% |
| 10 | VANGUARD FIDUCIARY TRUST CO | 124,576 | $734,998 | 0.0% | 0.3% | -6.0% |
| 11 | STATE STREET CORP | 92,124 | $543,532 | 0.0% | 0.3% | +81.5% |
| 12 | MILLENNIUM MANAGEMENT LLC | 82,499 | $486,744 | 0.0% | 0.2% | -20.3% |
| 13 | UBS Group AG | 53,276 | $314,329 | 0.0% | 0.1% | +134.2% |
| 14 | NORTHERN TRUST CORP | 49,090 | $289,631 | 0.0% | 0.1% | 0.0% |
| 15 | OSAIC HOLDINGS, INC. | 39,136 | $230,901 | 0.0% | 0.1% | +62.2% |
| 16 | MORGAN STANLEY | 35,515 | $209,539 | 0.0% | 0.1% | -1.6% |
| 17 | Jefferies Financial Group Inc.NEW | 18,100 | $106,790 | 0.0% | 0% | new |
| 18 | MARSHALL WACE, LLPNEW | 16,597 | $97,922 | 0.0% | 0% | new |
| 19 | ExodusPoint Capital Management, LPNEW | 14,029 | $82,771 | 0.0% | 0% | new |
| 20 | AXQ CAPITAL, LPNEW | 13,407 | $79,101 | 0.0% | 0% | new |
| 21 | Flatrock Wealth Partners LLC | 13,044 | $76,960 | 0.0% | 0% | 0.0% |
| 22 | TWO SIGMA INVESTMENTS, LPNEW | 11,101 | $65,496 | 0.0% | 0% | new |
| 23 | XTX Topco Ltd | 10,743 | $63,384 | 0.0% | 0% | -64.6% |
| 24 | Private Advisor Group, LLC | 10,416 | $61,454 | 0.0% | 0% | 0.0% |
| 25 | BNP PARIBAS FINANCIAL MARKETS | 5,801 | $34,226 | 0.0% | 0% | +8964.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.